Holen Sie sich die Stockscreener-App
7.36
2.65%
0.19
Vorhandelsmarkt:
7.35
-0.01
-0.14%
Schlusskurs vom Vortag:
$7.17
Offen:
$7.3
24-Stunden-Volumen:
1.05M
Relative Volume:
0.95
Marktkapitalisierung:
$455.76M
Einnahmen:
$170.16M
Nettoeinkommen (Verlust:
$-312.76M
KGV:
-1.2949
EPS:
-5.6837
Netto-Cashflow:
$-178.72M
1W Leistung:
+13.41%
1M Leistung:
-21.54%
6M Leistung:
-34.58%
1J Leistung:
+3.37%
1-Tages-Spanne:
$7.2645
$7.65
1-Wochen-Bereich:
$6.31
$7.65
52-Wochen-Spanne:
$5.00
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Firmenname
Ginkgo Bioworks Holdings Inc
Sektor
Branche
Telefon
(877) 442-5362
Adresse
27 DRYDOCK AVENUE, BOSTON
Compare DNA vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
7.36 | 455.76M | 170.16M | -312.76M | -178.72M | -5.6837 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-15 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-05-10 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-02 | Herabstufung | Goldman | Neutral → Sell |
| 2023-05-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Eingeleitet | Berenberg | Buy |
| 2022-10-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2022-02-23 | Eingeleitet | Goldman | Neutral |
| 2022-02-01 | Eingeleitet | BofA Securities | Neutral |
| 2022-01-28 | Eingeleitet | BofA Securities | Buy |
| 2022-01-07 | Eingeleitet | BTIG Research | Buy |
| 2021-11-29 | Eingeleitet | Jefferies | Buy |
| 2021-10-13 | Eingeleitet | Raymond James | Outperform |
| 2021-10-12 | Eingeleitet | William Blair | Outperform |
| 2021-09-20 | Eingeleitet | HSBC Securities | Buy |
Alle ansehen
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
(DNA) Risk Channels and Responsive Allocation - Stock Traders Daily
Ginkgo Bioworks Holdings, Inc. (DNA) increases despite market slip: Here's what you need to know - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) stock dips while market gains: Key facts - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) insider RSU vesting triggers tax share sale - Stock Titan
EBITDA per share of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Revenue per share of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
Book value per share of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView
708 Class A shares notified for sale; prior 972-share sale (DNA) - Stock Titan
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Pre - GuruFocus
Form 144 Ginkgo Bioworks Holdings For: 16 March By Investing.com - Investing.com Canada
How The Ginkgo Bioworks (DNA) Story Is Shifting As Analysts Revisit Growth And Risk - Yahoo Finance
Ginkgo Bioworks Posts On X "New in @sciam today: Researchers at Ginkgo and @OpenAI showed that an AI model working with an autonomous lab can design and iterate real biology experiments at unprecedented speed. From San Francisco, where GPT-5 - Benzinga
(DNA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Analysts Conflicted on These Healthcare Names: Valneva (VALN), Biogen (BIIB) and Ginkgo Bioworks Holdings (DNA) - The Globe and Mail
Ginkgo Bioworks (NYSE:DNA) Price Target Cut to $5.00 by Analysts at BTIG Research - MarketBeat
Ginkgo Bioworks (DNA): BTIG Analyst Lowers Price Target, Maintai - GuruFocus
Ginkgo Bioworks price target lowered to $5 from $9 at BTIG - TipRanks
BTIG cuts Ginkgo Bioworks stock price target on autonomous lab shift - Investing.com Canada
Ginkgo Bioworks Holdings Inc (DNA) PT Lowered to $5 at BTIG - StreetInsider
DNA (DNA) Form 144 shows director notices to sell 2,200 shares on two dates - Stock Titan
Risk Hedge: Why is Ginkgo Bioworks Holdings Inc stock going up2026 PreEarnings & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
DNA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Macro Review: Can Ginkgo Bioworks Holdings Inc expand into new marketsInsider Buying & High Win Rate Trade Alerts - baoquankhu1.vn
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen - Sahm
Ginkgo Bioworks (NYSE:DNA) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Ginkgo Bioworks Bets on Autonomous Labs Amid Headwinds - The Globe and Mail
Weekly Recap: Is Ginkgo Bioworks Holdings Inc attractive for institutional investorsWall Street Watch & Momentum Based Trading Signals - baoquankhu1.vn
DNA Earnings History & Surprises | EPS & Revenue Results | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
Ginkgo Bioworks Holdings, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:DNA) 2026-03-03 - Seeking Alpha
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 Earnings Call Transcript - Insider Monkey
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure - AI Insider
Ginkgo Bioworks Launches Ginkgo Cloud Lab to Provide Remote Access for Researchers - marketscreener.com
Ginkgo Bioworks Makes Major Pivot (NYSE:DNA) - Seeking Alpha
Ginkgo Bioworks Launches Ginkgo Cloud Lab - marketscreener.com
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
A Look At Ginkgo Bioworks (DNA) Valuation As It Pivots To Robotics Labs And Biosecurity Divestiture - Sahm
DNA SEC FilingsGinkgo Bioworks Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
A Look At Ginkgo Bioworks (DNA) Valuation After Earnings Update And Invaio Collaboration - Yahoo Finance
DNABW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Ginkgo Bioworks Q4 Loss Profile Reinforces Bearish Narratives On Cash Burn And Profit Timing - Sahm
Ginkgo Bioworks Q4 Earnings Call Highlights - MarketBeat
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of Its Non-Core Biosecurity Business - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and Xenon (XENE) - The Globe and Mail
Ginkgo Bioworks Holdings Inc (DNA) Q4 2025 Earnings Call Highlights: Strategic Shifts and ... By GuruFocus - Investing.com Canada
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter - Benzinga
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business - The Malaysian Reserve
Ginkgo Bioworks Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Ginkgo Bioworks Divests Biosecurity Unit, Retains Minority Stake - TipRanks
Finanzdaten der Ginkgo Bioworks Holdings Inc-Aktie (DNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):